SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950127-00-000141
Filing Date
2000-03-10
Accepted
2000-03-10 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT SC 13G 18536
  Complete submission text file 0000950127-00-000141.txt   20328
Mailing Address 600 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 600 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-553-2000
COULTER PHARMACEUTICALS INC (Subject) CIK: 0000942416 (see all company filings)

IRS No.: 943219075 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-52083 | Film No.: 565789
SIC: 2834 Pharmaceutical Preparations

Mailing Address TAUNUSANLAGE 12 D-60325 FRANKFURT AM MAIN I8
Business Address TAUNUSANLAGE 12 D-60325 FRANKFURT AM MAIN GE I8
DEUTSCHE BANK AG\ (Filed by) CIK: 0000948046 (see all company filings)

State of Incorp.: I8